Ashwin Kumar (@ashw1n) 's Twitter Profile
Ashwin Kumar

@ashw1n

Tweets to self

ID: 18238249

calendar_today19-12-2008 08:40:50

1,1K Tweet

257 Takipçi

693 Takip Edilen

Beyond Type 2 (@beyondtype2) 's Twitter Profile Photo

Abbott announced that the FreeStyle LibreLink app for Android users is now available in the U.S. The app was previously only available on iOS. #ADA2019 beyondtype2.org/breaking-news-…

Abbott (@abbottnews) 's Twitter Profile Photo

We’ve received FDA emergency use authorization and are immediately shipping 150,000 RealTime SARS-CoV-2 EUA tests for COVID-19. We’ll ramp up to a million tests per week by the end of the month: abbo.tt/3b8bASF 1/2

We’ve received FDA emergency use authorization and are immediately shipping 150,000 RealTime SARS-CoV-2 EUA tests for COVID-19. We’ll ramp up to a million tests per week by the end of the month: abbo.tt/3b8bASF 1/2
Scott Gottlieb, MD 🇺🇸 (@scottgottliebmd) 's Twitter Profile Photo

This is GAME CHANGER. Abbott to market, starting next week, a fast point-of-care #coronavirus test, delivering positive results in 5min and negative results in 13min. Will deliver 50K tests/day to start. Kudos to Abbott and FDA’s Jeff Shuren and team at CDRH who are in the fight.

Chetan Puttagunta (@chetanp) 's Twitter Profile Photo

I can already tell I'm going to be irritated next week when everyone learns how to pronounce "'X Æ A-12" and still struggle with "chetan"

Abbott (@abbottnews) 's Twitter Profile Photo

BREAKING: FreeStyle Libre 3 system receives CE Mark – features world's smallest, thinnest sensor with best-in-class performance at same low cost for people with diabetes. abbo.tt/3n2liNo

Abbott (@abbottnews) 's Twitter Profile Photo

FreeStyle Libre 3—the world's smallest, thinnest and most accurate 14-day continuous glucose monitoring system —is now FDA cleared in the U.S. for adults and children (4+ years) living with diabetes. abbo.tt/3M1IoPk ISI: abbo.tt/freestyle3

Abbott (@abbottnews) 's Twitter Profile Photo

We're creating a future where diabetes care is more personal. How? By developing a new sensor that will continuously monitor glucose and ketone levels, transforming care for those at risk of diabetic ketoacidosis. abbo.tt/3x6fXdx